Seven Fleet Capital Management LP
CIK
2092021
Location
MOUNTAIN VIEW, CA
Portfolio Value
Small
$146,379,580
Diversification
Moderately concentrated
Filing Date
Dec 31, 2025
Global Rank
#4,822
/ 8,420
Top Industry
Biotechnology
97.1%
3Y Alpha vs SPY
+39.2%
Period ended 6 months ago
Filed Apr 2, 2026 · 2mo
Clone Performance
Feb 2026–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+18.9%
SPY
+9.1%
Annualised alpha
+39.2%
Max drawdown
−16.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
81 positions · as of Dec 31, 2025Top Position
43.0%
of portfolio value
Top 5
59.5%
of portfolio value
Top 10
69.1%
of portfolio value
HHI
1,958
Moderately concentrated
Sector Breakdown
As of Dec 31, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $146,379,580 |
81 positions ·
$146,379,580 total
· as of Dec 31, 2025
Showing 1–50
of 81 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CGON |
CG Oncology, Inc.
Healthcare
|
First | 1,515,151 | $62,909,069 | 42.98% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
First | 214,099 | $7,604,796 | 5.20% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
First | 130,079 | $6,022,657 | 4.11% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
First | 130,413 | $5,268,685 | 3.60% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
First | 65,800 | $5,240,970 | 3.58% | |
| LQDA |
Liquidia Corp
Healthcare
|
First | 91,267 | $3,147,798 | 2.15% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
First | 568,747 | $3,054,171 | 2.09% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
First | 68,569 | $3,005,379 | 2.05% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
First | 73,762 | $2,508,645 | 1.71% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
First | 12,955 | $2,366,101 | 1.62% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
First | 79,560 | $2,091,632 | 1.43% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
First | 215,172 | $1,906,423 | 1.30% | |
| ABVX |
Abivax S.A.
Healthcare
|
First | 13,499 | $1,820,407 | 1.24% | |
| XNCR |
Xencor Inc
Healthcare
|
First | 109,554 | $1,677,271 | 1.15% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
First | 99,953 | $1,539,276 | 1.05% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
First | 55,342 | $1,535,740 | 1.05% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
First | 42,025 | $1,525,087 | 1.04% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
First | 9,161 | $1,465,393 | 1.00% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
First | 70,180 | $1,372,720 | 0.94% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
First | 12,601 | $1,267,534 | 0.87% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
First | 5,670 | $1,209,070 | 0.83% | |
| FOLD |
AMICUS THERAPEUTICS, INC.
Healthcare
|
First | 82,500 | $1,174,800 | 0.80% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
First | 25,365 | $1,170,341 | 0.80% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
First | 63,343 | $1,150,308 | 0.79% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
First | 533,648 | $1,093,978 | 0.75% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
First | 1,860 | $1,083,152 | 0.74% | |
| GERN |
Geron Corp
Healthcare
|
First | 777,880 | $1,026,801 | 0.70% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
First | 4,000 | $986,160 | 0.67% | |
| LONA |
LeonaBio, Inc.
Healthcare
|
First | 127,951 | $968,589 | 0.66% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
First | 167,223 | $919,726 | 0.63% | |
| SLN |
Silence Therapeutics plc
Healthcare
|
First | 147,600 | $897,408 | 0.61% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
First | 166,500 | $872,460 | 0.60% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
First | 31,738 | $863,908 | 0.59% | |
| CELC |
Celcuity Inc.
Healthcare
|
First | 8,338 | $831,632 | 0.57% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
First | 2,700 | $795,798 | 0.54% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
First | 48,412 | $781,853 | 0.53% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
First | 327,500 | $769,625 | 0.53% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
First | 154,109 | $744,346 | 0.51% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
First | 8,000 | $698,720 | 0.48% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
First | 10,335 | $656,685 | 0.45% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
First | 15,000 | $634,200 | 0.43% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
First | 73,000 | $617,580 | 0.42% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
First | 14,651 | $603,767 | 0.41% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
First | 18,200 | $574,028 | 0.39% | |
| EOLS |
Evolus, Inc.
Healthcare
|
First | 82,000 | $545,300 | 0.37% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
First | 20,600 | $542,398 | 0.37% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
|
First | 56,750 | $461,945 | 0.32% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
First | 14,654 | $456,032 | 0.31% | |
| PRTA |
Prothena Corp Public Ltd Co
Healthcare
|
First | 43,300 | $413,515 | 0.28% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
First | 20,000 | $379,400 | 0.26% |